Meningeal interleukin-17-producing T cells mediate cognitive impairment in a mouse model of salt-sensitive hypertension

Monica M. Santisteban,Samantha Schaeffer,Antoine Anfray,Giuseppe Faraco,David Brea,Gang Wang,Melissa J. Sobanko,Rose Sciortino,Gianfranco Racchumi,Ari Waisman,Laibaik Park,Josef Anrather,Costantino Iadecola
DOI: https://doi.org/10.1038/s41593-023-01497-z
IF: 25
2023-12-04
Nature Neuroscience
Abstract:Hypertension (HTN), a disease afflicting over one billion individuals worldwide, is a leading cause of cognitive impairment, the mechanisms of which remain poorly understood. In the present study, in a mouse model of HTN, we find that the neurovascular and cognitive dysfunction depends on interleukin (IL)-17, a cytokine elevated in individuals with HTN. However, neither circulating IL-17 nor brain angiotensin signaling can account for the dysfunction. Rather, IL-17 produced by T cells in the dura mater is the mediator released in the cerebrospinal fluid and activating IL-17 receptors on border-associated macrophages (BAMs). Accordingly, depleting BAMs, deleting IL-17 receptor A in brain macrophages or suppressing meningeal T cells rescues cognitive function without attenuating blood pressure elevation, circulating IL-17 or brain angiotensin signaling. Our data unveil a critical role of meningeal T cells and macrophage IL-17 signaling in the neurovascular and cognitive dysfunction in a mouse model of HTN.
neurosciences
What problem does this paper attempt to address?